Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 2Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 38Prostatic Neoplasms 18Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lung Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Neoplasms 14Leukemia 13Rectal Neoplasms 12Uterine Cervical Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 10Colorectal Neoplasms 10Colonic Neoplasms 10Sarcoma 9Leukemia, Myeloid, Acute 8Central Nervous System Neoplasms 8Brain Neoplasms 8Pain 7Ovarian Neoplasms 7Neuroblastoma 7Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Head and Neck Neoplasms 7Small Cell Lung Carcinoma 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Carcinoma, Ovarian Epithelial 6Burkitt Lymphoma 6Testicular Neoplasms 5Sezary Syndrome 5

Interventions

Etoposide 1Carboplatin 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NIH × Ovarian Germ Cell Cancer × Clear all
NCT00276718 2013-09-17

Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors

National Cancer Institute (NCI)

Phase NA Unknown
100 enrolled
CNSGenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡